The real challenge lies in identifying metabolic/PCD internal phenotypes that are more likely to benefit from Nrf2 or mTOR/AMPK regulation in the highly heterogeneous COPD population, using oxidative stress biomarkers (such as 8-iso-PGF 2 , MDA), iron metabolism indicators, mitochondrial function, and autophagic flux-related biological markers, and implementing time-limited interventions within appropriate time windows (such as during acute exacerbation recovery or in high-risk stable populations), rather than long-term, indiscriminately pulling these basic metabolic pathways (298, 299)
V., Lapin, B
1822 GLP-1 receptor agonists exhibit several cardioprotective mechanisms that make them interesting candidates for the treatment of HF
Tissue injury was assessed semi-quantitatively using a 03 grading system (0 = none, 1 = mild, 2 = moderate, 3 = severe) for parameters including muscle-fiber degeneration, edema, vascular congestion, and inflammatory infiltration in ten randomly selected fields per sample